Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) Interest & Investment Income (2016 - 2026)

Pediatrix Medical (MD) has disclosed Interest & Investment Income for 17 consecutive years, with $4.7 million as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income rose 66.01% to $4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.0 million through Dec 2025, up 230.01% year-over-year, with the annual reading at $19.0 million for FY2025, 230.01% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $4.7 million at Pediatrix Medical, down from $5.9 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $6.0 million in Q1 2021, with the low at -$161000.0 in Q2 2024.
  • Average Interest & Investment Income over 5 years is $2.3 million, with a median of $1.8 million recorded in 2021.
  • The sharpest move saw Interest & Investment Income plummeted 113.54% in 2024, then surged 2414.91% in 2025.
  • Over 5 years, Interest & Investment Income stood at $1.8 million in 2021, then fell by 26.77% to $1.3 million in 2022, then surged by 67.94% to $2.2 million in 2023, then increased by 26.23% to $2.8 million in 2024, then surged by 66.01% to $4.7 million in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $4.7 million, $5.9 million, and $3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.